Bernadette V Marquez et al.
Molecular pharmaceutics, 11(11), 3988-3995 (2014-07-25)
Pertuzumab is a monoclonal antibody that binds to HER2 and is used in combination with another HER2-specific monoclonal antibody, trastuzumab, for the treatment of HER2+ metastatic breast cancer. Pertuzumab binds to an HER2 binding site distinct from that of trastuzumab